Roche Stock Price, News & Analysis (VTX:ROG)

CHF 222.05 -1.25 (-0.56 %)
(As of 02/23/2018 04:00 PM ET)
Previous CloseCHF 222.05
Today's RangeCHF 220.35 - CHF 222.95
52-Week RangeCHF 214.30 - CHF 273
Volume1.83 million shs
Average Volume2.33 million shs
Market Capitalization$190.98 billion
P/E Ratio22.12
Dividend Yield3.74%
BetaN/A

About Roche (VTX:ROG)

Roche logoRoche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Receive ROG News and Ratings via Email

Sign-up to receive the latest news and ratings for ROG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diversified Electronics
Sub-IndustryN/A
SectorHealthcare
SymbolVTX:ROG
CUSIPN/A
Phone+41-9-732354295

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio22.1165338645418
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSCHF 10.04
Net IncomeN/A
Net Margins21.17%
Return on Equity46.76%
Return on Assets14.96%

Miscellaneous

EmployeesN/A
Outstanding Shares693,300,000

Roche (VTX:ROG) Frequently Asked Questions

What is Roche's stock symbol?

Roche trades on the VTX under the ticker symbol "ROG."

Where is Roche's stock going? Where will Roche's stock price be in 2018?

19 Wall Street analysts have issued 1 year target prices for Roche's shares. Their predictions range from CHF 190 to CHF 325. On average, they anticipate Roche's stock price to reach CHF 260.61 in the next twelve months. View Analyst Ratings for Roche.

Who are some of Roche's key competitors?

Who are Roche's key executives?

Roche's management team includes the folowing people:

  • Severin Schwan, Chairman of the Corporate Executive Committee, Chief Executive Officer, Executive Director (Age 51)
  • Alan Hippe, Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer (Age 51)
  • Sophie Kornowski-Bonnet, Member of the Enlarged Corporate Executive Committee, Head Roche Partnering (Age 54)
  • Osamu Nagayama, Member of the Enlarged Corporate Executive Committee, Chairman and Chief Executive Officer Chugai (Age 70)
  • John C. Reed M.D., Ph.D., Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development (Age 60)
  • Michael David Varney, Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development (Age 60)
  • Cristina A. Wilbur, Member of the Executive Committee, Head Group Human Resources (Age 51)
  • Urs Jaisli, Chief Compliance Officer (Age 62)
  • Gottlieb A. Keller, Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors (Age 64)
  • Stephan Feldhaus, Member of the Enlarged Corporate Executive Committee, Head Group Communications (Age 56)

What is Roche's stock price today?

One share of Roche stock can currently be purchased for approximately CHF 222.05.

How big of a company is Roche?

Roche has a market capitalization of $190.98 billion.

How can I contact Roche?

Roche's mailing address is Grenzacherstr. 124, BASEL, 4058, Switzerland. The healthcare company can be reached via phone at +41-9-732354295.


MarketBeat Community Rating for Roche (ROG)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  294 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  398
MarketBeat's community ratings are surveys of what our community members think about Roche and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Roche (VTX:ROG) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.372.332.312.58
Ratings Breakdown: 3 Sell Rating(s)
6 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: CHF 260.61CHF 262.18CHF 265.56CHF 276.55

Roche (VTX:ROG) Consensus Price Target History

Price Target History for Roche (VTX:ROG)

Roche (VTX:ROG) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/20/2018Kepler Capital MarketsSet Price TargetNeutralCHF 236View Rating Details
2/13/2018Goldman Sachs GroupSet Price TargetBuyCHF 325View Rating Details
2/5/2018BarclaysSet Price TargetBuyCHF 295View Rating Details
2/5/2018Deutsche BankSet Price TargetNeutralCHF 240View Rating Details
2/2/2018DZ BankSet Price TargetBuyCHF 270View Rating Details
2/2/2018JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details
2/2/2018Sanford C. BernsteinSet Price TargetBuyCHF 250View Rating Details
1/15/2018Societe GeneraleSet Price TargetSellCHF 190View Rating Details
1/5/2018Jefferies GroupSet Price TargetBuyCHF 300View Rating Details
1/2/2018Nord/LBReiterated RatingBuyView Rating Details
12/8/2017Morgan StanleySet Price TargetNeutralCHF 260View Rating Details
12/6/2017Bank of AmericaSet Price TargetBuyCHF 275View Rating Details
11/22/2017Liberum CapitalSet Price TargetBuyCHF 279View Rating Details
11/21/2017Baader BankSet Price TargetBuyCHF 256View Rating Details
11/21/2017HSBCSet Price TargetSellCHF 205View Rating Details
11/20/2017Berenberg BankSet Price TargetNeutralCHF 260View Rating Details
10/18/2017CitigroupSet Price TargetNeutralCHF 255View Rating Details
10/16/2017Credit Suisse GroupSet Price TargetNeutralCHF 260View Rating Details
9/25/2017BNP ParibasSet Price TargetSellCHF 235View Rating Details
(Data available from 2/24/2016 forward)

Earnings

Earnings History for Roche (VTX:ROG)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Roche (VTX:ROG) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Roche (VTX:ROG)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roche (VTX ROG)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Roche (VTX ROG) News Headlines

Source:
DateHeadline
Roche Holding Ltd. (ROG) Receives Consensus Rating of "Hold" from AnalystsRoche Holding Ltd. (ROG) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - February 21 at 3:34 AM
Roche (ROG) Given a CHF 236 Price Target at Kepler Capital MarketsRoche (ROG) Given a CHF 236 Price Target at Kepler Capital Markets
www.americanbankingnews.com - February 20 at 6:16 PM
Roche (ROG) PT Set at CHF 237 by UBS GroupRoche (ROG) PT Set at CHF 237 by UBS Group
www.americanbankingnews.com - February 20 at 6:26 AM
Roche (ROG) Given a CHF 325 Price Target by Goldman Sachs Group AnalystsRoche (ROG) Given a CHF 325 Price Target by Goldman Sachs Group Analysts
www.americanbankingnews.com - February 19 at 4:46 PM
Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio - ReutersRoche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio - Reuters
www.reuters.com - February 17 at 8:12 AM
Roche to acquire cancer software company Flatiron for $1.9 billion - MarketWatchRoche to acquire cancer software company Flatiron for $1.9 billion - MarketWatch
www.marketwatch.com - February 16 at 8:15 AM
3 Biotechs That Could Benefit From an M&A Frenzy3 Biotechs That Could Benefit From an M&A Frenzy
www.msn.com - February 15 at 5:22 PM
UK cost watchdog backs Roches Gazyvaro for certain follicular lymphoma patientsUK cost watchdog backs Roche's Gazyvaro for certain follicular lymphoma patients
seekingalpha.com - February 10 at 3:43 PM
Roche (ROG) Given a CHF 260 Price Target at UBS GroupRoche (ROG) Given a CHF 260 Price Target at UBS Group
www.americanbankingnews.com - February 6 at 1:56 PM
Roche (ROG) Given a CHF 295 Price Target by Barclays AnalystsRoche (ROG) Given a CHF 295 Price Target by Barclays Analysts
www.americanbankingnews.com - February 5 at 6:02 PM
Roche (ROG) Given a CHF 240 Price Target at Deutsche BankRoche (ROG) Given a CHF 240 Price Target at Deutsche Bank
www.americanbankingnews.com - February 5 at 6:46 AM
Roche (ROG) PT Set at CHF 250 by Sanford C. BernsteinRoche (ROG) PT Set at CHF 250 by Sanford C. Bernstein
www.americanbankingnews.com - February 3 at 6:00 PM
Roche (ROG) Given a CHF 270 Price Target at DZ BankRoche (ROG) Given a CHF 270 Price Target at DZ Bank
www.americanbankingnews.com - February 2 at 2:52 PM
Roches (ROG) "Buy" Rating Reiterated at JPMorgan Chase & Co.Roche's (ROG) "Buy" Rating Reiterated at JPMorgan Chase & Co.
www.americanbankingnews.com - February 2 at 10:28 AM
Roche Holding Ltd. (ROG) Receives Average Rating of "Hold" from AnalystsRoche Holding Ltd. (ROG) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - January 27 at 3:50 AM
Kepler Capital Markets Analysts Give Roche (ROG) a CHF 226 Price TargetKepler Capital Markets Analysts Give Roche (ROG) a CHF 226 Price Target
www.americanbankingnews.com - January 17 at 11:22 AM
Roche (ROG) Given a CHF 190 Price Target by Societe Generale AnalystsRoche (ROG) Given a CHF 190 Price Target by Societe Generale Analysts
www.americanbankingnews.com - January 15 at 7:28 PM
UBS Group Reiterates "Neutral" Rating for Roche (ROG)UBS Group Reiterates "Neutral" Rating for Roche (ROG)
www.americanbankingnews.com - January 15 at 11:02 AM
Deutsche Bank Analysts Give Roche (ROG) a CHF 264 Price TargetDeutsche Bank Analysts Give Roche (ROG) a CHF 264 Price Target
www.americanbankingnews.com - January 15 at 8:08 AM
Roche (ROG) Rating Reiterated by JPMorgan Chase & Co.Roche (ROG) Rating Reiterated by JPMorgan Chase & Co.
www.americanbankingnews.com - January 11 at 6:06 AM
Roche, GE to develop digital diagnostics platform - MarketWatchRoche, GE to develop digital diagnostics platform - MarketWatch
www.marketwatch.com - January 10 at 11:10 AM
Roche (ROG) PT Set at CHF 260 by UBS GroupRoche (ROG) PT Set at CHF 260 by UBS Group
www.americanbankingnews.com - January 8 at 6:38 AM
Roche (ROG) PT Set at CHF 300 by Jefferies GroupRoche (ROG) PT Set at CHF 300 by Jefferies Group
www.americanbankingnews.com - January 5 at 6:38 AM
Roche Holding Ltd. (ROG) Receives Consensus Recommendation of "Hold" from AnalystsRoche Holding Ltd. (ROG) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 2 at 3:56 AM
Sanford C. Bernstein Analysts Give Roche (ROG) a CHF 262 Price TargetSanford C. Bernstein Analysts Give Roche (ROG) a CHF 262 Price Target
www.americanbankingnews.com - December 30 at 5:52 PM
Roche (ROG) Given a CHF 260 Price Target by Morgan Stanley AnalystsRoche (ROG) Given a CHF 260 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - December 30 at 5:14 PM
Barclays Reiterates CHF 305 Price Target for Roche (ROG)Barclays Reiterates CHF 305 Price Target for Roche (ROG)
www.americanbankingnews.com - December 29 at 6:32 PM
Roche (ROG) Given a CHF 300 Price Target at JPMorgan Chase & Co.Roche (ROG) Given a CHF 300 Price Target at JPMorgan Chase & Co.
www.americanbankingnews.com - December 29 at 2:50 PM
Roche (ROG) Receives "Buy" Rating from Nord/LBRoche (ROG) Receives "Buy" Rating from Nord/LB
www.americanbankingnews.com - December 27 at 8:48 AM
Did Rogers Corporation (NYSE:ROG) Create Value For Shareholders?Did Rogers Corporation (NYSE:ROG) Create Value For Shareholders?
finance.yahoo.com - December 20 at 11:08 AM
Goldman Sachs Group Analysts Give Roche (ROG) a CHF 325 Price TargetGoldman Sachs Group Analysts Give Roche (ROG) a CHF 325 Price Target
www.americanbankingnews.com - December 17 at 3:08 PM
Roche (ROG) Given a CHF 290 Price Target at J P Morgan Chase & CoRoche (ROG) Given a CHF 290 Price Target at J P Morgan Chase & Co
www.americanbankingnews.com - December 16 at 10:38 PM
Deutsche Bank Reiterates CHF 264 Price Target for Roche (ROG)Deutsche Bank Reiterates CHF 264 Price Target for Roche (ROG)
www.americanbankingnews.com - December 12 at 10:48 AM
Roche reports positive results from cancer drug - MarketWatchRoche reports positive results from cancer drug - MarketWatch
www.marketwatch.com - December 11 at 11:48 AM
Morgan Stanley Reiterates CHF 260 Price Target for Roche (ROG)Morgan Stanley Reiterates CHF 260 Price Target for Roche (ROG)
www.americanbankingnews.com - December 8 at 10:34 AM
Roche (ROG) PT Set at CHF 290 by J P Morgan Chase & CoRoche (ROG) PT Set at CHF 290 by J P Morgan Chase & Co
www.americanbankingnews.com - December 8 at 6:20 AM
Roche Holding Ltd. (ROG) Receives Consensus Rating of "Hold" from BrokeragesRoche Holding Ltd. (ROG) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 8 at 3:52 AM
Roche (ROG) Given a CHF 275 Price Target by Bank of America AnalystsRoche (ROG) Given a CHF 275 Price Target by Bank of America Analysts
www.americanbankingnews.com - December 6 at 6:26 PM
UBS Reiterates "CHF 260" Price Target for Roche (ROG)UBS Reiterates "CHF 260" Price Target for Roche (ROG)
www.americanbankingnews.com - December 6 at 10:08 AM
Roche Holding Ltd. (ROG) PT Set at CHF 254 by Deutsche Bank AGRoche Holding Ltd. (ROG) PT Set at CHF 254 by Deutsche Bank AG
www.americanbankingnews.com - November 23 at 6:34 PM
Roche Holding Ltd. (ROG) PT Set at CHF 279 by Liberum CapitalRoche Holding Ltd. (ROG) PT Set at CHF 279 by Liberum Capital
www.americanbankingnews.com - November 22 at 6:10 AM
Roche Holding Ltd. (ROG) Given a CHF 205 Price Target at HSBC Holdings PLCRoche Holding Ltd. (ROG) Given a CHF 205 Price Target at HSBC Holdings PLC
www.americanbankingnews.com - November 21 at 10:58 PM
Roche Holding Ltd. (ROG) PT Set at CHF 256 by Baader BankRoche Holding Ltd. (ROG) PT Set at CHF 256 by Baader Bank
www.americanbankingnews.com - November 21 at 4:06 PM
Roche jumps on positive lung cancer drug dataRoche jumps on positive lung cancer drug data
finance.yahoo.com - November 21 at 9:57 AM
Berenberg Bank Analysts Give Roche Holding Ltd. (ROG) a CHF 260 Price TargetBerenberg Bank Analysts Give Roche Holding Ltd. (ROG) a CHF 260 Price Target
www.americanbankingnews.com - November 20 at 6:52 AM
Goldman Sachs Group, Inc. (The) Analysts Give Roche Holding Ltd. (ROG) a CHF 325 Price TargetGoldman Sachs Group, Inc. (The) Analysts Give Roche Holding Ltd. (ROG) a CHF 325 Price Target
www.americanbankingnews.com - November 20 at 6:14 AM
Zacks.com highlights: Jones Lang LaSalle, Rogers, PBF Energy, Westlake Chemical and DXC TechnologyZacks.com highlights: Jones Lang LaSalle, Rogers, PBF Energy, Westlake Chemical and DXC Technology
finance.yahoo.com - November 18 at 11:28 AM
Roche Holding Ltd. (ROG) Earns "Buy" Rating from J P Morgan Chase & CoRoche Holding Ltd. (ROG) Earns "Buy" Rating from J P Morgan Chase & Co
www.americanbankingnews.com - November 18 at 11:00 AM
Roche Holding Ltd. (ROG) Given a CHF 260 Price Target by Morgan Stanley AnalystsRoche Holding Ltd. (ROG) Given a CHF 260 Price Target by Morgan Stanley Analysts
www.americanbankingnews.com - November 17 at 4:42 PM
Roche Holding Ltd. (ROG) Given a CHF 254 Price Target by Deutsche Bank AG AnalystsRoche Holding Ltd. (ROG) Given a CHF 254 Price Target by Deutsche Bank AG Analysts
www.americanbankingnews.com - November 17 at 10:30 AM

SEC Filings

Roche (VTX:ROG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Roche (VTX ROG) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.